ERIC AVERY, M.D.
Hematology & Oncology Physician · LINCOLN, NE
Individual Active NPI 1093934598
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,001 | 355,847 | $28,833,972 | $8,126,919 | $6,493,170 |
| 2023 | 922 | 278,570 | $14,814,362 | $5,650,399 | $4,511,071 |
| 2022 | 964 | 263,258 | $12,498,752 | $5,661,495 | $4,533,762 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 66,550 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 29,800 | $56 | $45 |
| J0185 | Injection, aprepitant, 1 mg | 21,060 | $2 | $1 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 18,020 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 17,920 | $31 | $25 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 16,200 | $49 | $39 |
| J1453 | Injection, fosaprepitant, 1 mg | 14,700 | $0 | $0 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 11,250 | $45 | $36 |
| J0897 | Injection, denosumab, 1 mg | 8,340 | $26 | $21 |
| J9173 | Injection, durvalumab, 10 mg | 7,200 | $80 | $64 |
| J9267 | Injection, paclitaxel, 1 mg | 5,130 | $0 | $0 |
| J9171 | Injection, docetaxel, 1 mg | 4,998 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 24810 | NE |
| Medical Oncology Physician | 207RX0202X | 24810 | NE |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Nebraska
- NPI 1164412425
- NPI 1053301317
- NPI 1740714419
- NPI 1144522780
- NPI 1437111408
- NPI 1255417580
- NPI 1114006988
- NPI 1669636643
See all Hematology & Oncology Physician providers in Nebraska →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.